Skip to content

Opening book details…

About this Medicine article

The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study by Ronsley, Rebecca; Kariminia, Amina; Ng, Bernard; Mostafavi, Sara; Reid, Gregor; Subrt, Peter; Hijiya, Nobuko; Schultz, Kirk R. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Ronsley, Rebecca; Kariminia, Amina; Ng, Bernard; Mostafavi, Sara; Reid, Gregor; Subrt, Peter; Hijiya, Nobuko; Schultz, Kirk R.
Publisher
Informa plc; Informa UK (Taylor & Francis); Taylor & Francis; Informa UK Limited (ISSN 0888-0018)
Published
2019
Language
EN
Field
Medicine (Health Sciences)

More by Ronsley, Rebecca; Kariminia, Amina; Ng, Bernard; Mostafavi, Sara; Reid, Gregor; Subrt, Peter; Hijiya, Nobuko; Schultz, Kirk R.

Browse all works by Ronsley, Rebecca; Kariminia, Amina; Ng, Bernard; Mostafavi, Sara; Reid, Gregor; Subrt, Peter; Hijiya, Nobuko; Schultz, Kirk R.